Can-Fite BioPharma Ltd.
10 Bareket Street
Kiryat Matalon, P.O. Box 7537
Petach-Tikva 4951778, Israel
January 13, 2022
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||Can-Fite BioPharma Ltd.|
|Registration Statement on Form F-3|
|File No. 333-262055|
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Can-Fite BioPharma Ltd. (the “Company”) hereby respectfully requests that the effectiveness of the Registration Statement on Form F-3 (File No. 333-262055) of the Company (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 4:00 p.m., Eastern Time, on January 14, 2022 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, McDermott Will & Emery LLP, by calling Gary Emmanuel at (212) 547-5541. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
|Very truly yours,|
|CAN-FITE BIOPHARMA LTD.|
|By:||/s/ Pnina Fishman, Ph.D.|
|Name:||Pnina Fishman, Ph.D.|
|Title:||Chief Executive Officer|
|cc:||Gary Emmanuel (McDermott Will & Emery LLP)|